One of the top domestic policy challenges facing the incoming Trump administration is the fundamental reform of federal public health agencies.
President Donald Trump and his new team can draw upon a treasure trove of congressional findings. For example, the House Subcommittee on Oversight and Investigations (a panel of the Energy and Commerce Committee) has recently released a remarkable report on the Biden-Harris administration’s $900 million public relations campaign to sell its scientifically defective COVID-19 policies.
No congressional panel, however, has done more to shine the light on these problems than the House Select Subcommittee on the Coronavirus Pandemic, chaired by Rep. Brad Wenstrup, R-Ohio. Subcommittee members have made commendable efforts to examine systemic failures over the past two years, and their investigations have also unveiled a…
